The pathogenesis of molybdenum cofactor deficiency, its delay by maternal clearance, and its expression pattern in microarray analysis

Molecular Genetics and Metabolism

Volumn 85, Issue 1, 2005, Pages 12-20

  Reiss, Jochen ^a   Bonin, Michael ^b   Schwegler, Herbert ^c   Sass, Jörn Oliver ^d   Garattini, Enrico ^e   Wagner, Silke ^a   Lee, Heon Jin ^a   Engel, Wolfgang ^a   Riess, Olaf ^b   Schwarz, Günter ^f  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b Max Plank Inst fur E   (Germany)

^c OTTO VON GUERICKE UNIVERSITY   (Germany)

^d UNIVERSITY OF FREIBURG   (Germany)

^e MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^f TECHNICAL UNIVERSITY OF BRAUNSCHWEIG   (Germany)

Author keywords

Cofactor; Maternal clearance; MOCS1; Molybdenum; Sulfite

Indexed keywords

MOLYBDENUM; MOLYBDOPTERIN; SULFATE; SULFITE; SULFITE OXIDASE;

ANIMAL TISSUE; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CELL DEATH; CLEARANCE; DNA MICROARRAY; GENE EXPRESSION; MOLYBDENUM COFACTOR DEFICIENCY; MOTHER FETUS RELATIONSHIP; MOUSE; NEUROLOGIC DISEASE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SEIZURE;

ANIMALIA; MURINAE;

EID: 20944445194     PISSN: 10967192     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ymgme.2005.01.008     Document Type: Article

References (35)

1. K.V. Rajagopalan, and J.L. Johnson The pterin molybdenum cofactors J. Biol. Chem. 267 1992 10199
2. E. Garattini, R. Mendel, M.J. Romao, R. Wright, and M. Terao Mammalian molybdo-flavoenzymes, an expanding family of proteins: structure, genetics, regulation, function and pathophysiology Biochem. J. 372 2003 15
3. J.L. Johnson, and M. Duran Molybdenum cofactor deficiency and isolated sulfite oxidase deficiency C. Scriver A. Beaudet W. Sly D. Valle The metabolic and molecular bases of inherited disease 2001 McGraw-Hill New York 3163
4. H.A. Simmonds, S. Reiter, and T. Nishino Hereditary xanthinuria C.R. Scriver A.L. Beaudet W.S. Sly D. Valle The metabolic and molecular bases of inherited disease 1995 McGraw-Hill New York 1781
5. K.V. Rajagopalan Molybdopterin-problems and perspectives Biofactors 1 1988 273
6. V.E. Shih, I.F. Abroms, J.L. Johnson, M. Carney, R. Mandell, R.M. Robb, J.P. Cloherty, and K.V. Rajagopalan Sulfite oxidase deficiency. Biochemical and clinical investigations of a hereditary metabolic disorder in sulfur metabolism N. Engl. J. Med. 297 1977 1022
7. S.K. Wadman, M. Duran, F.A. Beemer, B.P. Cats, J.L. Johnson, K.V. Rajagopalan, J.M. Saudubray, H. Ogier, C. Charpentier, and R. Berger Absence of hepatic molybdenum cofactor: an inborn error of metabolism leading to a combined deficiency of sulphite oxidase and xanthine dehydrogenase J. Inherit. Metab. Dis. 6 1983 78
8. H.J. Lee, I.M. Adham, G. Schwarz, M. Kneussel, J.O. Sass, W. Engel, and J. Reiss Molybdenum cofactor-deficient mice resemble the phenotype of human patients Hum. Mol. Genet. 11 2002 3309
9. R.R. Mendel, and G. Schwarz Biosynthesis and molecular biology of the molybdenum cofactor (Moco) Met. Ions Biol. Syst. 39 2002 317
10. J. Reiss, N. Cohen, C. Dorche, H. Mandel, R.R. Mendel, B. Stallmeyer, M.T. Zabot, and T. Dierks Mutations in a polycistronic nuclear gene associated with molybdenum cofactor deficiency Nat. Genet. 20 1998 51
11. J. Reiss, C. Dorche, B. Stallmeyer, R.R. Mendel, N. Cohen, and M.T. Zabot Human molybdopterin synthase gene: genomic structure and mutations in molybdenum cofactor deficiency type B Am. J. Hum. Genet. 64 1999 706
12. J. Reiss, and J.L. Johnson Mutations in the molybdenum cofactor biosynthetic genes MOCS1, MOCS2, and GEPH Hum. Mutat. 21 2003 569
13. J. Reiss Genetics of molybdenum cofactor deficiency Hum. Genet. 106 2000 157
14. J.L. Johnson, M.M. Wuebbens, R. Mandell, and V.E. Shih Molybdenum cofactor biosynthesis in humans. Identification of two complementation groups of cofactor-deficient patients and preliminary characterization of a diffusible molybdopterin precursor J. Clin. Invest. 83 1989 897
15. J. Reiss, E. Christensen, G. Kurlemann, M.-T. Zabot, and C. Dorche MOCS1 gene defective in molybdenum cofactor deficiency type A Hum. Genet. 103 1998 639
16. G. Schwarz, J.A. Santamaria-Araujo, S. Wolf, H.J. Lee, I.M. Adham, H.J. Grone, H. Schwegler, J.O. Sass, T. Otte, P. Hanzelmann, R.R. Mendel, W. Engel, and J. Reiss Rescue of lethal molybdenum cofactor deficiency by a biosynthetic precursor from Escherichia coli Hum. Mol. Genet. 13 2004 1249
17. B. Romeis, Mikroskopische Technik, Urban and Schwarzenberg, München, 1989
18. G. Liu, A.E. Loraine, R. Shigeta, M. Cline, J. Cheng, V. Valmeekam, S. Sun, D. Kulp, and M.A. Siani-Rose NetAffx: affymetrix probesets and annotations Nucleic Acids Res. 31 2003 82
19. A. Sturn, J. Quackenbush, and Z. Trajanoski Genesis: cluster analysis of microarray data Bioinformatics 18 2002 207
20. A. Nason, K.Y. Lee, S.S. Pan, P.A. Ketchum, A. Lamberti, and J. DeVries Invitro formation of assimilatory reduced nicotinamide adenine dinucleotide phosphate: nitrate reductase from a Neurospora mutant and a component of molybdenum-enzymes Proc. Natl. Acad. Sci. USA 68 1971 3242
21. M. Jaffe Ueber den Niederschlag, welchen Pikrinsaeure in normalem Harn erzeugt und ueber eine neue Reaction des Kreatinins Physiol. Chem. 10 1886 391 400
22. M. Kneussel, and H. Betz Clustering of inhibitory neurotransmitter receptors at developing postsynaptic sites: the membrane activation model Trends Neurosci. 23 2000 429
23. K. Lieuallen, L.A. Pennacchio, M. Park, R.M. Myers, and G.G. Lennon Cystatine B-deficient mice have increased expression of apoptosis and glial activation genes Hum. Mol. Genet. 10 2001 1867
24. R.P. Grewal, T.E. Morgan, and C.E. Finch C1qB and clusterin mRNA increase in association with neurodegeneration in sporadic amyotrophic lateral sclerosis Neurosci. Lett. 271 1999 65
25. E. del Valle, A. Navarro, A. Astudillo, and J. Tolivia Apolipoprotein D expression in human brain reactive astrocytes J. Histochem. Cytochem. 51 2003 1285
26. M.G. Walker Z39Ig is co-expressed with activated macrophage genes Biochim. Biophys. Acta 1574 2002 387
27. H.S. Salman, K. Tanaka, and J.A. Sparano Phase I/II trial of gemcitabine plus cyclophosphamide in patients with metastatic breast carcinoma previously treated with taxanes Clin. Breast Cancer 2 2002 299
28. J.L. Johnson, H.P. Jones, and K.V. Rajagopalan In vitro reconstitution of demolybdosulfite oxidase by a molybdenum cofactor from rat liver and other sources J. Biol. Chem. 252 1977 4994
29. L.R. Devireddy, J.G. Teodoro, F.A. Richard, and M.R. Green Induction of apoptosis by a secreted lipocalin that is transcriptionally regulated by IL-3 deprivation Science 293 2001 829
30. Q. Liu, and M. Nilsen-Hamilton Identification of a new acute phase protein J. Biol. Chem. 270 1995 22565
31. W.D. Graf, O.E. Oleinik, R.M. Jack, A.H. Weiss, and J.L. Johnson Ahomocysteinemia in molybdenum cofactor deficiency Neurology 51 1998 860
32. S. Dorion, H. Lambert, and J. Landry Activation of the p38 signaling pathway by heat shock involves the dissociation of glutathione S-transferase Mu from Ask1 J. Biol. Chem. 277 2002 30792
33. K.A. Marshall, M. Reist, P. Jenner, and B. Halliwell The neuronal toxicity of sulfite plus peroxynitrite is enhanced by glutathione depletion: implications for Parkinson's disease Free Radic. Biol. Med. 27 1999 515
34. X. Zhang, A.S. Vincent, B. Halliwell, and K.P. Wong A mechanism of sulfite neurotoxicity: direct inhibition of glutamate dehydrogenase J. Biol. Chem. 2004
35. A.S. Vincent, B.G. Lim, J. Tan, M. Whiteman, N.S. Cheung, B. Halliwell, and K.P. Wong Sulfite-mediated oxidative stress in kidney cells Kidney Int. 65 2004 393